SCLE 13D/13G Filings - Broadscale Acquisition Corp.

Real time Form 13D and 13G transaction reports:

Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
Shares have beem adjusted for stock split.

"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>

Reported DateTime	Transaction Date	Type	Company Symbol	Filed By Symbol	Shares Owned % Owned	Shares Vs. Prev Report	View
2023-02-06 3:05 pm Sale	2022-12-31	13G	Broadscale Acquisition Corp. SCLE	Weiss Asset Management LP	0 0.000%	-2,000,225 (Position Closed)	Filing History
2022-02-11 5:09 pm Purchase	2021-12-31	13G	Broadscale Acquisition Corp. SCLE	Sculptor Capital LP	2,286,879 6.630%	2,286,879 (New Position)	Filing History
2022-02-08 4:00 pm Purchase	2021-12-31	13G	Broadscale Acquisition Corp. SCLE	COHEN JONATHAN Z	8,625,000 20.000%	8,625,000 (New Position)	Filing History
2022-02-04 3:07 pm Purchase	2021-12-31	13G	Broadscale Acquisition Corp. SCLE	Weiss Asset Management LP	2,000,225 5.800%	2,000,225 (New Position)	Filing History
2022-01-21 4:32 pm Purchase	2021-12-31	13G	Broadscale Acquisition Corp. SCLE	Integrated Core Strategies (US) LLC	939,461 2.700%	939,461 (New Position)	Filing History
2021-03-18 2:34 pm Purchase	2021-03-15	13G	BROADSCALE ACQ CORP UNIT 1 CL SCLEU	Sculptor Capital LP	1,933,382 5.600%	1,933,382 (New Position)	Filing History
2021-02-22 4:32 pm Purchase	2021-02-12	13G	BROADSCALE ACQ CORP UNIT 1 CL SCLEU	Integrated Core Strategies (US) LLC	2,250,000 6.500%	2,250,000 (New Position)	Filing History
2021-02-18 08:13 am Purchase	2021-02-12	13G	Biotech Acquisition Company BIOTU	Vellar Opportunities Fund Master Ltd.	2,700,000 9.000%	2,700,000 (New Position)	Filing History